|
2025
|
Invention
|
Small-molecule compound having glp-1 receptor agonist activity and use thereof. A GLP-1 receptor ... |
|
|
Invention
|
Method for preparing androgen receptor-targeted degradation compound and salt thereof. A method f... |
|
2024
|
Invention
|
Drug for treating triple negative breast cancer.
Provided is a drug for treating triple negative... |
|
|
Invention
|
Combination drug for treating triple-negative breast cancer.
A combination drug for treating tri... |
|
|
Invention
|
Pi3k inhibitor, and preparation method therefor and use thereof. Disclosed is a compound represen... |
|
|
Invention
|
Combined drug of estrogen protein targeted degrader and use thereof. Provided are a combined drug... |
|
|
Invention
|
Combined drug for degrading estrogen receptor and use thereof. A combined drug for degrading an e... |
|
|
Invention
|
Quinoline compound sustained-release tablet and preparation method therefor.
This patent documen... |
|
|
P/S
|
Pharmaceuticals, namely, pharmaceutical preparations and pharmaceutical products for treatment of... |
|
2023
|
Invention
|
Combination therapy for treating ovarian cancer. The present invention relates to the field of ph... |
|
|
Invention
|
Pi3k inhibitor, preparation method therefor, and use thereof. The present invention belongs to th... |
|
|
Invention
|
Aromatic compound, method for preparing same, and use thereof in preparation of estrogen receptor... |
|
|
Invention
|
Combination drug for treating triple-negative breast cancer. A combination drug for treating trip... |
|
|
Invention
|
Drug for treating triple negative breast cancer. Provided is a drug for treating triple negative ... |
|
|
Invention
|
Deuterated heterocyclic ketone compound and use thereof.
A compound represented by formula (I) o... |
|
|
Invention
|
Deuterated heterocyclic ketone compound and use thereof. The present invention relates to a compo... |
|
|
Invention
|
Method for preparing industrialized mass production hc-1119 soft capsule. A method for the indust... |
|
2022
|
Invention
|
Bifunctional chimeric heterocyclic compound and use thereof as androgen receptor degrader.
A com... |
|
|
Invention
|
Bifunctional chimeric heterocyclic compound and use thereof as androgen receptor degrader. A comp... |
|
|
Invention
|
Synthesis and application of phosphatase degrader.
A synthesis and an application of a phosphata... |
|
|
Invention
|
Synthesis and application of phosphatase degrader. A synthesis and an application of a phosphatas... |
|
|
Invention
|
Pharmaceutical composition for treatment of cancer and use thereof.
A pharmaceutical composition... |
|
|
Invention
|
Pharmaceutical composition for treatment of cancer and use thereof. A pharmaceutical composition ... |
|
|
Invention
|
Synthesis method for aminopyrimidine fak inhibitor compound.
A synthesis method for an aminopyri... |
|
|
Invention
|
Synthesis method for aminopyrimidine fak inhibitor compound. A synthesis method for an aminopyrim... |
|
2021
|
Invention
|
Quinoline compound sustained-release tablet and preparation method therefor. Disclosed in the pre... |
|
|
Invention
|
Brd4 inhibitor as well as a preparative method and use thereof. The compound of formula (I) has a... |
|
|
Invention
|
Deuterated imidazolidinedione compounds and their uses.
Provided herein is a compound of Formula... |
|
2020
|
Invention
|
Ep300/cbp inhibitor.
An EP300/CBP inhibitor, specifically provided is a compound as shown in for... |
|
|
Invention
|
Ep300/cbp inhibitor. An EP300/CBP inhibitor, specifically provided is a compound as shown in form... |
|
|
Invention
|
Halogen-substituted phenylate compound and applications thereof. A compound of formula (I) or an ... |
|
|
Invention
|
Halogen-substituted phenylate compound and applications thereof. Disclosed in the present inventi... |
|
|
Invention
|
Aromatic amine ar ahd bet targeting protein degradation chimera compound and use.
An aromatic am... |
|
|
Invention
|
Aromatic amine ar and bet targeting protein degradation chimera compound and use. An aromatic ami... |
|
|
Invention
|
Bifunctional chimeric heterocyclic compounds for targeted degradation of androgen receptors and u... |
|
|
Invention
|
A class of bifunctional chimeric heterocyclic compounds for targeted degradation of androgen rece... |
|
|
Invention
|
Aromatic amine compound and use thereof in preparation of ar and brd4 dual inhibitors and regulat... |
|
2019
|
Invention
|
Fak inhibitor and drug combination thereof. A deuterated compound as represented by formula (I) o... |
|
|
Invention
|
Histone acetylase p300 inhibitor and use thereof.
A compound represented by formula (I), or a st... |
|
|
Invention
|
Histone acetylase p300 inhibitor and use thereof. Provided are a histone acetylase p300 inhibitor... |
|
|
Invention
|
Brd4 inhibitor, preparation method and use thereof. Provided are a compound as depicted in formul... |
|
|
Invention
|
Deuterated mgl-3196 compound and use thereof.
Disclosed are a compound as shown in formula (I) o... |
|
|
Invention
|
Hc-1119 formulation, preparation method and use thereof.
A formulation of androgen receptor inhi... |
|
|
Invention
|
Deuterated defactinib compound and use thereof. This disclosure provides a compound as shown in f... |
|
|
Invention
|
Method for synthesis of deuterated amide and deuterated sulfonamide. 5, or a salt and base thereo... |
|
|
Invention
|
Indoleamine-2,3-dioxygenase inhibitor, preparation method therefor and use thereof. A compound is... |
|
2018
|
Invention
|
Indoleamine-2,3-dioxygenase inhibitor, the preparative method and the use thereof. Provided is a ... |
|
|
Invention
|
Brd4 inhibitor. Disclosed is a BRD4 inhibitor as shown in formula I, belonging to the field of co... |
|
2016
|
Invention
|
Method for preparing deuterated imidazole diketone compound.
A method for preparation of deutera... |
